Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa

Future Microbiology

Volumn 3, Issue 2, 2008, Pages 191-203

  Kintz, Erica ^a   Goldberg, Joanna B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Biogenesis; Environmental stimuli; Immunodominant; Lipopolysaccharide; LPS; O antigen; Outer membrane; Pseudomonas aeruginosa; Virulence factors

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE O ANTIGEN; PROTEIN WZZ; PROTEIN WZZ1; PROTEIN WZZ2; REGULATOR PROTEIN;

ANTIGEN EXPRESSION; BACTERIAL METABOLISM; BACTERIAL OUTER MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL STRESS; COMPLEX FORMATION; CYSTIC FIBROSIS; CYTOPLASM; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; GENE EXPRESSION REGULATION; GRAM NEGATIVE INFECTION; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; REVIEW; TRANSCRIPTION REGULATION;

LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; O ANTIGENS; PSEUDOMONAS AERUGINOSA;

ANIMALIA; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 47249138658     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.2.191     Document Type: Review

References (55)

1. Jarvis WR, Marione WJ: Predominant pathogens in hospital infections. J. Antimicrobiol. Chemother. 29(Suppl.), A19-A24 (1992).
2. Lyczak JB, Cannon CL, Pier GB: Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15(2), 194-222 (2002).
3. Miller SI, Ernst RK, Bader MW: LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3(1), 36-46 (2005).
4. Ernst RK, Moskowitz SM, Emerson JC et al.: Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J. Infect. Dis. 196(7), 1088-1092 (2007).
5. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI: Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3(4), 354-359 (2002).
6. Pier GB, Grout M, Zaidi TS et al.: Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271(5245), 64-67 (1996).
7. Zaidi TS, Priebe GP, Pier GB: A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Infect. Immun. 74(2), 975-983 (2006).
8. Wilkinson SG, Galbraith L: Studies of lipopolysaccharides from Pseudomonas aeruginosa. Eur. J. Biochem. 52(2), 331-343 (1975).
9. Bystrova OV, Knirei YA, Lindner B et al.: Structures of the core oligosaccharide and O-units in the R- and SR-type lipopolysaccharides of reference strains of Pseudomonas acruginosa O-serogroups. FEMS Immunol. Med. Microbiol. 46(1), 85-99 (2006).
10. Pier GB, Grout M, Zaidi TS: Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl Acad. Sci. USA 94(22), 12088-12093 (1997).
11. Rocchetta HL, Burrows LL, Lam JS: Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa Microbiol. Mol. Biol. Rev. 63(3), 523-553 (1999).
12. Knirel YA, Bystrova OV, Kocharova NA, Zahringer U, Pier GB: Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa. J. Endotoxin Res. 12(6), 324-336 (2006).
13. Raymond CK, Sims EH, Kas A et al.: Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J. Bacteriol. 184(13), 3614-3622 (2002).
14. Yokota S, Kaya S, Sawada S, Kawamura T, Araki Y, Ito E: Characterization of a polysaccharide component of lipopolysaccharide from Pseudomonas aeruginosa IID 1008 (ATCC 27584) as D-rhamnan. Eur. J. Biochem. 167(2), 203-209 (1987).
15. Currie HL, Lightfoot J, Lam JS: Prevalence of gca, a gene involved in synthesis of A-band common antigen polysaccharide in Pseudomonas aeruginosa. Clin. Diagn. Lab. Immunol. 2(5), 554-562 (1995).
16. Hatano K, Goldberg JB, Pier GB: Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect. Immun. 63(1), 21-26 (1995).
17. Makin SA, Beveridge TJ: The influence of A-band and B-band lipopolysaccharide on the surface characteristics and adhesion of Pseudomonas aeruginosa to surfaces. Microbiology 142(2), 299-307 (1996).
18. Burrows LL, Rocchetta HL, Lam JS: Assembly pathways for biosynthesis of A-band and B-band lipopolysaccharide in Pseudomonas aeroginosa. In: GlycoMicrobiology. Doyle RJ (Ed.), Kluwer Academic/Plenum Publishers, NY, USA 127-143 (2000).
19. Morona R, Van Den Bosch L, Daniels C: Evaluation of Wzz/MPA1/MPA2 proteins based on the presence of coiled-coil regions. Microbiology 146(1), 1-4 (2000).
20. Ruiz N, Kahne D, Silhavy TJ: Advances in understanding bacterial outer-membrane biogenesis. Nat. Rev. Microbiol. 4(1), 57-66 (2006).
21. Kintz E, Scarrf JM, DiGiandomenico A, Goldberg JB: Lipopolysaccharide O antigen chain length regulation in Psudomonas aeruginosa serogroup, O11 strain PA103. J. Bacteriol. (2008) (In press).
22. Burrows LL, Lam JS: Effect of wzx (rfbx) mutations on A-band and B-band lipopolysaccharide biosynthesis in Pseudomonas aeruginosa O5. J. Bacteriol. 181(3), 973-980 (1999).
23. Priebe GP, Dean CR, Zaidi T et al.: The galU gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infect. Immun. 72(7), 4224-4232 (2004).
24. Cryz SJ Jr, Pitt TL, Furer E, Germanier R: Role of lipopolysaccharide in virulence of Pseudomanas aeruginasa. Infect. Immun. 44(2), 508-513 (1984).
25. Tang HB, DiMango E, Bryan R et al.: Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64(1), 37-43 (1996).
26. Dasgupta T, de Kievit TR, Masoud H et al.: Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6. Infect. Immun. 62(3), 809-817 (1994).
27. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB: Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable, strains, deficient in lipopolysaccharide O side chains. Infect. Immun. 42(1), 170-177 (1983).
28. Evans DJ, Pier GB, Coyne MJ, Goldberg JB: The rib locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients. Mol. Microbiol. 13(3), 427-434 (1994).
29. Morona R, van den Bosch L, Manning PA: Molecular, genetic, and topological characterization of O-antigen chain length regulation in Shigella fleneri. J. Bacteriol. 177(4), 1059-1068 (1995)
30. Murray GL, Attridge SR, Morona R: Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol. Microbiol. 47(5), 1395-1406 (2003).
31. Stevenson G, Kessler A, Reeves PR: A plasmid-borne O-antigen chain length determinant and its relationship to other chain length determinants. FEMS Microbiol. Lett. 125(1), 23-30 (1995).
32. Daniels C, Griffiths G, Cowles B, Lam JS: Pseudomonas aeruginosa O-antigen chain length is determined before ligation to lipid A core. Environ. Microbiol. 4(12), 883-897 (2002).
33. Bastin DA, Stevenson G, Brown PK, Haase A, Reeves PR: Repeat unit polysaccharldes of bacteria: a model for polymerization resembling that of ribosonres and fatty acid synthetase, with a novel mechanism for determining chain length. Mol. Microbiol. 7(5), 725-734 (1993).
34. Franco AV, Liu D, Reeves PR: The wzz(cld) protein in Escherichia colt. amino acid sequence variation determines O-antigen chain length specificity. J. Bacteriol. 180(10), 2670-2675 (1998).
35. Daniels C, Morona R: Analysis of Shigella flexneri wzz (Rol) function by mutagenesis and cross-linking: wzz is able to oligomerize. Mol. Microbiol. 34(1), 181-194 (1999).
36. Marolda CL, Haggerty ER, Lung M, Valvano MA: Functional analysis of predicted coiled coil regions in the Escherichia coli K-12 O antigen polysaccharide chain length determinant Wzz. J. Bacteriol. DOI: 10.1128/JB.01746-07 (2008) (Epub ahead of print).
37. Morona R, Daniels C, Van Den Bosch L: Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence. Microbiology 149(4), 925-939 (2003).
38. Murray GL, Attridge SR, Morona R: Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement. J. Bacteriol. 188(7), 2735-2739 (2006).
39. Tang KH, Guo H, Yi W, Tsai MD, Wang PG: Investigation of the conformational states of Wzz and the Wzz.O-antigen complex under near-physiological conditions. Biochemistry 46(42), 11744-11752 (2007).
40. Guo H, Lokko K, Zhang Y, Yi W, Wu Z, Wang PG: Overexpression and characterization of Wzz of Escherichia coli O86:H2. Protein Expr. Purif. 48(1), 49-55 (2006).
41. Hong M, Payne SM: Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol. Mcrobiol. 24(4), 779-791 (1997).
42. Jin Q, Yuan Z, Xu J et al.: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of EScherichia coli K12 and O157. Nucleic Acids Res. 30(20), 4432-4441 (2002).
43. Sandlin RC, Lampel KA, Keasier SP, Goldberg MB, Stoizer AL, Maurelli AT: Avirulence of rough mutants of Shigella flexneri. requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect. Immun. 63(1), 229-237 (1995).
44. Makin SA, Beveridge TJ: Pseudomonas aeruginosa PAO1 ceases to express serotype-specific lipopolysaccharide at 45 degrees C. J. Bacteriol. 178(11), 3350-3352 (1996).
45. Sabra W, Lunsdorf H, Zeng AP: Alterations in the formation of lipopolysaccharide and membrane vesicles on the surface of Pseudomonas aeruginosa PAOI under oxygen strem conditions. Microbiology 149(10), 2789-2795 (2003).
46. McGroarty EJ, Rivera M: Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1. Infect Immun. 58(4), 1030-1037 (1990).
47. Bittner M, Saldias S, Altamirano F, Valvano MA, Contreras I: RpoS and RpoN are involved in the growth-dependent regulation of rfaH transcription and O antigen expression in Salmonella enterica serovar Typhi. Microb. Pathog. 36(1), 19-24 (2004).
48. Carter JA, Blondel CJ, Zaldivar M et al.: O-antigen modal chain length in Shigella flexneri 2a is growth-regulated through RfaH-mediated transcriptional control of the wzy gene. Microbiology 153(10), 3499-3507 (2007).
49. Murray GL, Attridge SR, Morona R: Inducible serum resistance in Salmonella typhimurium is dependent on wzz(fePE) regulated very long O antigen chains. Microbes Infect. 7(13), 1296-1304 (2005).
50. Varela G, Schelotto F, di Conza J, Ayala JA: Analysis of the O-antigen chain length distribution during extracellular and intracellular growth of Shigella flexneri. Microb. Pathog. 31(1), 21-27 (2001).
51. Vines ED, Marolda CL, Balachandran A, Valvano MA: Defective O-antigen polymerization in tolA and paI mutants of Escherichia coli in response to extracytoplasmic stress. J. Bacteriol. 187(10), 3359-3368 (2005).
52. Gaspar JA, Thomas JA, Maroida CL, Valvano MA: Surface expression of O-specific lipopolysaccharide in Escherichia coli requires the function of the TolA protein. Mol. Microbiol. 38(2), 262-275 (2000).
53. Bengoechea JA, Zhang L, Toivanen P, Skurnik M: Regulatory network of lipopolysaccharide O-antigen biosynthesis in Yersinia enterocalitica includes cell envelope-dependent signals. Mol. Microbiol. 44(4), 1045-1062 (2002).
54. Delgado MA, Mouslim C, Groisman EA: The PmrA/PmrB and RcsC/YojN/RcsB systems control expression of the Salmonella O-antigen chain length determinant. Mol. Microbiol. 60(1), 39-50 (2006).
55. Daniels C, Vindurampulle C, Morona R: Overexpression and topology of the Shigella flexnri O-antigen polymerase (Rfc/Wzy). Mol. Microbiol. 28(6), 1211-1222 (1998).